Diabetes Symptoms News

User Rating: / 1
PoorBest 

Tuesday, Feb 23, 2010
The US Senate Finance Committee has released a report, which followed a two-year inquiry into the safety of the diabetes drug Avandia (rosiglitazone), and the possibility of an increased incidence of adverse cardiovascular events...
Read story...
Tuesday, Feb 23, 2010
According to research from Edinburgh University, stress increases the risk of memory loss and cognitive decline in older people with Type 2 diabetes. Analysing 900 men and women aged between 60 and 75 with Type 2 diabetes, the study found brain function slowed down in those who had higher levels of the stress hormone cortisol in their blood...
Read story...
Tuesday, Feb 23, 2010
Women who gain excessive weight during pregnancy, especially in the first trimester, may increase their risk of developing diabetes later in their pregnancy, according to a study by the Kaiser Permanente Division of Research that appears online in the current issue of Obstetrics and Gynecology...
Read story...
Tuesday, Feb 23, 2010
This study shows that older people with diabetes who have higher levels of stress hormones in their blood are more likely to have experienced cognitive decline...
Read story...
Tuesday, Feb 23, 2010
"Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market ... ," The New York Times reports. "The internal F.D.A...
Read story...
Tuesday, Feb 23, 2010
Diabetes UK's Measure Up Roadshow 2010 kicked off this month and will be touring the country until the end of October in a bid to help people find out more about Type 2 diabetes and its risk factors. It has encouraged thousands of people in the UK to measure their waists and find out if they are at risk of developing Type 2 diabetes...
Read story...
Tuesday, Feb 23, 2010
We are calling fundraisers from all over the South East to don their running shoes and race the 10 mile Great South Run, on Sunday 24th October, around the historic town of Portsmouth to help raise funds for diabetes research. We are offering guaranteed places in this fast growing European road race for all Diabetes UK recruits...
Read story...
Tuesday, Feb 23, 2010
More and more reports have been surfacing about weight-loss surgery "curing" type 2 diabetes. At the same time, more and more questions are being asked about this process, how it works, who it works for, and how long it may continue to work...
Read story...
Monday, Feb 22, 2010
The Department of Health has released its 'Six Years On: Delivering the Diabetes National Service Framework' report, which updates on the progress made since the National Service Framework (NSF) for Diabetes was developed in 2001, setting out national standards of care for people with diabetes...
Read story...
Monday, Feb 22, 2010
The eyes may be the window to the soul, but research is demonstrating that the mouth is the gateway to good health. In fact, a dental exam can reveal early symptoms of more than 100 diseases, as well as identify gum disease, which can have a negative effect on the body's overall health...
Read story...
Monday, Feb 22, 2010
The American Association for Dental Research (AADR) has announced Isabel Gay as the recipient of the 2010 AADR William B. Clark Fellowship in Clinical Research. This award will be announced at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010. Gay is an assistant professor in the Department of Periodontics, University of Texas, Health Science at Houston...
Read story...
Sunday, Feb 21, 2010
Patients on statins may have a slight increased risk of developing diabetes, according to new research published The Lancet . The authors examined data from a number of sources to resolve doubts around the issue following results from other studies...
Read story...
Saturday, Feb 20, 2010
Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that VEGF Trap-Eye showed positive results in a Phase II study in patients with Diabetic Macular Edema (DME). The primary endpoint of the study, a statistically significant improvement in visual acuity over 24 weeks compared to the standard of care in DME, macular laser treatment, was met...
Read story...
Saturday, Feb 20, 2010
A Stratton Spotlight article recently highlighted a Centers for Disease Control and Prevention (CDC) survey that showed a dramatic rise in the number of diabetes cases during the last 10 years and noted that pharmaceutical research and biotechnology companies are working on nearly 200 new medicines to treat this debilitating disease...
Read story...
Friday, Feb 19, 2010
A panel of governmental, academic and non-profit scientists speaking at the annual meeting of the American Association for the Advancement of Science (AAAS) unveiled research suggesting that diseases found in dolphins are similar to human diseases and can provide clues into how human health might be affected by exposure to contaminated coastal water or seafood...
Read story...
Friday, Feb 19, 2010
An international group of medical experts has crafted a much-needed classification system for diabetic nephropathy, the leading cause of total kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN)...
Read story...
Friday, Feb 19, 2010
The drug avosentan substantially reduces urinary protein loss in people with type 2 diabetes and kidney disease, but the drug causes serious side effects, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that lower doses of avosentan may have a more favorable risk/benefit ratio for patients...
Read story...
Friday, Feb 19, 2010
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare AG announced that VEGF Trap-Eye showed positive results in a Phase 2 study in patients with diabetic macular edema (DME). The primary endpoint of the study, a statistically significant improvement in visual acuity over 24 weeks compared to the standard of care in DME, macular laser therapy, was met...
Read story...
Friday, Feb 19, 2010
In the not-too-distant future we could see diabetes, the seventh leading cause of death in the U.S., treated with a vaccine. Several vaccine candidates are in the pipeline, creating a possible $2...
Read story...
Thursday, Feb 18, 2010
For years, biologists have wondered how it is possible that not every person who carries a mutated gene expresses the trait or condition associated with the mutation. This common but poorly understood phenomenon, known as incomplete penetrance, exists in a wide range of organisms, including humans...
Read story...
Thursday, Feb 18, 2010
We just need a few hundred more people to sign up and we will have over 6,000 'Get Serious' supporters. The Get Serious campaign aims to underline the seriousness of diabetes and is all about strength in numbers. We're aiming to get as many of our supporters as possible to sign up and show their commitment to Get Serious about diabetes...
Read story...
Thursday, Feb 18, 2010
Marcadia Biotech Inc. announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing...
Read story...
Thursday, Feb 18, 2010
A new study has shown that the use of statins in people aged 60 and over increases the risk of developing Type 2 diabetes by nine per cent. The researchers, however, stressed the risk is low, especially when compared with the beneficial effect that statins have on reducing heart problems...
Read story...
Thursday, Feb 18, 2010
People who get plenty of vitamin D can cut their chance of developing Type 2 diabetes by 55 per cent. Researchers from the Warwick Medical School reviewed 28 existing studies on almost 100,000 people looking at vitamin D levels among middle-aged and elderly people. They also found high levels of vitamin D reduced the risk of cardiovascular disease by 33 per cent...
Read story...
Wednesday, Feb 17, 2010
A study by CVS Caremark (NYSE: CVS), published this week in the American Journal of Pharmacy Benefits, finds that insurance benefit designs that reduce the cost of medications for plan participants result in patients being more likely to start and stay on their medication therapy...
Read story...